Pricing Log in Create free account

Dyadic International Inc. (DYAI) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Dyadic International Inc. and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Dyadic International Inc. and Radiopharm Theranostics Limited - Sponsored ADR are of similar size ($17.0M and $16.8M). Across the 8 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 5 and Dyadic International Inc. on 3.

Valuation

Metric DYAI RADX Biotechnology median
P/E n/m — 8.50
P/S 3.93 — 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.03 n/m 9.21
Earnings yield (56.10%) — (33.15%)
Free cash flow yield (50.30%) 0.00% (25.50%)

Profitability

Metric DYAI RADX Biotechnology median
Gross margin 16.24% — 65.16%
Operating margin (195.47%) — 0.00%
Net margin (200.46%) — 0.00%
Free cash flow margin (194.73%) 0.00% 0.00%
Return on equity 522.58% 0.00% (56.36%)
Return on assets (103.88%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DYAI RADX Biotechnology median
Revenue growth (TTM) (8.05%) — 6.02%
EPS growth (last fiscal year) (15.00%) (1.97%) 30.26%
Revenue growth, 5-year CAGR 14.04% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DYAI RADX Biotechnology median
Debt to equity (2.11) 0.00 0.00
Current ratio 1.65 1.16 4.72
Net debt to EBITDA 0.49 0.08 0.96

Dividend

Metric DYAI RADX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DYAI RADX Biotechnology median
Market cap 16.80m 16.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack